DG
Insider
Douglas Michael Garis
EVP&CFODouglas Michael Garis (EVP&CFO) filed 2 Form 4 reports in the past 24 months (2 purchases, 0 sales), most often in Claritev Corporation (CTEV). Across 2 priced purchase filings, the average 21-session return was +35.1% from execution and +43.2% from disclosure (delay-adjusted; derived). The largest single filing was $632K of CTEV (28,749 sh across 2 lots, as filed), executed May 12 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+35.1%
avg across 2 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+43.2%
same 2 filings, from disclosure
Filings, ttm
2
2 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$794K
shares × price, as filed
Last traded
May 12 2025
Filed May 13 2025
Median ADV $4.5M across their filed names
Open performance→Volume by month
Buys $794K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 24 months
Most traded names
CTEV
Claritev Corporation
CTEV · 2 buys · 0 sells
2 filings
Recent filings
CTEVPURCHASE
Claritev Corporation
View filing →
$632K28,749 sh across 2 lots
Exec May 12 2025
Filed May 13 2025 · 5:30 PM ET CTEVPURCHASE Claritev Corporation View filing → $162K
8,238 sh × $19.62
Exec Mar 7 2025
Filed Mar 10 2025 · 5:30 PM ET